Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Suckling in PWS Infants
NCT02205034Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- May 2013
- Primary completion
- Jul 2014
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in Prader-Willi syndrome (PWS), sponsored by Centre hospitalier universitaire de Toulouse. Started May 2013; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT02205034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02205034.